/Companies

Esperion Therapeutics

Ann Arbor, US · 12 known investors

Find your way into Esperion Therapeutics

Sign up to see every warm intro you have to Esperion Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Esperion Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Biopharma developing HDL-C regulating therapies; listed 2000.

Founders & leadership

RS
Roger S. NewtonFounder
TM
Tim M. MaylebenExecutive

Board

DJ
Daniel JanneyBoard director
DA
Dov A. GoldsteinBoard directorManaging Partner at Aisling Capital
NVNicole Vitullo
Nicole VitulloBoard directorInvestor at Arboretum Ventures
PEPatrick Enright
Patrick EnrightBoard directorManaging Director at Longitude Capital
AM
Antonio M. Gotto, Jr.Board director
GS
Gilbert S. OmennBoard director
ME
Mark E. McGovernBoard director

Investors · 12

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedJul 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Antonio M. Gotto, Jr.Director
  • Tim M. MaylebenExecutive Officer, Director
  • Gilbert S. OmennDirector
  • Daniel JanneyDirector
  • Dov A. GoldsteinDirector
  • Nicole VitulloDirector
  • Roger S. NewtonDirector
  • Patrick EnrightDirector
  • Mark E. McGovernDirector
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Esperion Therapeutics went on to found or lead other companies.

In the news

Frequently asked questions

What does Esperion Therapeutics do?
Biopharma developing HDL-C regulating therapies; listed 2000.
Who founded Esperion Therapeutics?
Esperion Therapeutics was founded by Roger S. Newton.
Who are Esperion Therapeutics's investors?
Esperion Therapeutics's investors include Aisling Capital, Alta Partners, Arboretum Ventures, ARCHIMED Japan, Asset Management Company, Canaan Partners, HealthCap, HEALTHCARE ROYALTY PARTNERS and 4 more.
Where is Esperion Therapeutics headquartered?
Esperion Therapeutics is headquartered in Ann Arbor, US.